معرفی
Dr. Giulio Nannetti is a Lecturer at Swansea University Medical School, specializing in Pharmacy. He holds a Master’s in Medical Biotechnologies (University of Siena) and a PhD in Biomedicine (University of Padua). His research focuses on antiviral drug discovery, targeting viral protein-protein interactions for influenza, dengue, and norovirus infections. Notably, he received the Marie Skłodowska-Curie Individual Fellowship (2018) for developing antiviral drugs against dengue virus. He teaches modules including Foundations of Pharmacy Practice and contributes to the MPharm program’s patient-centered learning modules.
- Education:
- PhD in Biomedicine, University of Padua (2018)
- MSc in Medical Biotechnologies, University of Siena (2013)
- Affiliations:
- Reviewer Board Member of Life (2020–present)
- Topics Board Editor of Viruses (2021–present)
His research interests span antiviral strategies, molecular modeling, and health sciences education. He has contributed to over 20 peer-reviewed publications, including work on norovirus polymerase inhibitors and MASP-2 targeting for coronavirus treatments. He actively engages in public outreach, such as science festivals and European Researchers’ Night events.
Dr. Nannetti’s academic roles include postgraduate supervision and collaborative research projects, emphasizing interdisciplinary approaches to antiviral drug development.
